Innovative Pharmaceutical Biotech Limited (0399.HK)
HKD 0.17
(4.85%)
HKD 0.17
(4.85%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 661.64 Million HKD | 586.05% |
| 2022 | 96.44 Million HKD | -89.28% |
| 2021 | 899.95 Million HKD | 269.09% |
| 2020 | 243.83 Million HKD | -68.76% |
| 2019 | 780.56 Million HKD | 10.0% |
| 2018 | 709.58 Million HKD | 26.16% |
| 2017 | 562.43 Million HKD | 17.98% |
| 2016 | 476.73 Million HKD | 16.91% |
| 2015 | 407.79 Million HKD | 14.88% |
| 2014 | 354.95 Million HKD | 579.63% |
| 2013 | 52.22 Million HKD | 249.05% |
| 2012 | 14.96 Million HKD | 0.0% |
| 2011 | - HKD | 0.0% |
| 2010 | - HKD | 0.0% |
| 2009 | - HKD | 0.0% |
| 2008 | - HKD | 0.0% |
| 2007 | - HKD | 0.0% |
| 2006 | - HKD | 0.0% |
| 2005 | - HKD | 0.0% |
| 2004 | - HKD | -100.0% |
| 2003 | 585 Million HKD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 Q2 | 671.17 Million HKD | 0.0% |
| 2023 Q1 | 671.17 Million HKD | 595.94% |
| 2023 FY | 661.64 Million HKD | 586.05% |
| 2023 Q4 | 661.64 Million HKD | -1.54% |
| 2023 Q3 | 671.99 Million HKD | 0.12% |
| 2022 FY | 96.44 Million HKD | -89.28% |
| 2022 Q3 | 96.44 Million HKD | -66.75% |
| 2022 Q4 | 96.44 Million HKD | 0.0% |
| 2022 Q2 | 290.01 Million HKD | 0.0% |
| 2022 Q1 | 290.01 Million HKD | -67.78% |
| 2021 Q1 | 834.51 Million HKD | 242.25% |
| 2021 Q2 | 834.51 Million HKD | 0.0% |
| 2021 Q3 | 899.95 Million HKD | 7.84% |
| 2021 Q4 | 899.95 Million HKD | 0.0% |
| 2021 FY | 899.95 Million HKD | 269.09% |
| 2020 FY | 243.83 Million HKD | -68.76% |
| 2020 Q4 | 243.83 Million HKD | 0.0% |
| 2020 Q2 | 200.86 Million HKD | 0.0% |
| 2020 Q3 | 243.83 Million HKD | 21.39% |
| 2020 Q1 | 200.86 Million HKD | -74.27% |
| 2019 Q4 | 780.56 Million HKD | 0.0% |
| 2019 Q2 | 770.04 Million HKD | -5.98% |
| 2019 FY | 780.56 Million HKD | 10.0% |
| 2019 Q1 | 818.99 Million HKD | 15.42% |
| 2019 Q3 | 780.56 Million HKD | 1.37% |
| 2018 Q2 | 599.62 Million HKD | -10.7% |
| 2018 Q3 | 751.54 Million HKD | 25.34% |
| 2018 Q4 | 709.58 Million HKD | -5.58% |
| 2018 FY | 709.58 Million HKD | 26.16% |
| 2018 Q1 | 671.47 Million HKD | 19.39% |
| 2017 Q4 | 562.43 Million HKD | -6.94% |
| 2017 Q3 | 604.38 Million HKD | 19.6% |
| 2017 Q2 | 505.32 Million HKD | 0.0% |
| 2017 Q1 | 505.32 Million HKD | 6.0% |
| 2017 FY | 562.43 Million HKD | 17.98% |
| 2016 Q3 | 476.73 Million HKD | 11.37% |
| 2016 Q4 | 476.73 Million HKD | 0.0% |
| 2016 Q1 | 428.04 Million HKD | 4.97% |
| 2016 FY | 476.73 Million HKD | 16.91% |
| 2016 Q2 | 428.04 Million HKD | 0.0% |
| 2015 Q2 | 369.85 Million HKD | 0.0% |
| 2015 Q3 | 407.79 Million HKD | 10.26% |
| 2015 Q4 | 407.79 Million HKD | 0.0% |
| 2015 Q1 | 369.85 Million HKD | 4.2% |
| 2015 FY | 407.79 Million HKD | 14.88% |
| 2014 Q3 | 354.95 Million HKD | 15.46% |
| 2014 FY | 354.95 Million HKD | 579.63% |
| 2014 Q1 | 307.44 Million HKD | 488.65% |
| 2014 Q4 | 354.95 Million HKD | 0.0% |
| 2014 Q2 | 307.44 Million HKD | 0.0% |
| 2013 Q3 | 50.17 Million HKD | 0.0% |
| 2013 Q4 | 52.22 Million HKD | 4.08% |
| 2013 FY | 52.22 Million HKD | 249.05% |
| 2013 Q1 | 14.96 Million HKD | 0.0% |
| 2013 Q2 | 50.17 Million HKD | 235.35% |
| 2012 FY | 14.96 Million HKD | 0.0% |
| 2012 Q2 | 9.25 Million HKD | 50.82% |
| 2012 Q1 | 6.13 Million HKD | 0.0% |
| 2012 Q3 | 9.25 Million HKD | 0.0% |
| 2012 Q4 | 14.96 Million HKD | 61.76% |
| 2011 FY | - HKD | 0.0% |
| 2011 Q3 | - HKD | 0.0% |
| 2011 Q1 | - HKD | 0.0% |
| 2010 Q3 | - HKD | 0.0% |
| 2010 Q1 | - HKD | 0.0% |
| 2010 FY | - HKD | 0.0% |
| 2009 FY | - HKD | 0.0% |
| 2008 FY | - HKD | 0.0% |
| 2007 FY | - HKD | 0.0% |
| 2006 FY | - HKD | 0.0% |
| 2005 FY | - HKD | 0.0% |
| 2004 FY | - HKD | -100.0% |
| 2003 FY | 585 Million HKD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Natural Beauty Bio-Technology Limited | 3.49 Million HKD | -18814.951% |
| China Overseas Nuoxin International Holdings Limited | 9.2 Million HKD | -7090.23% |
| Prosperous Future Holdings Limited | 6.33 Million HKD | -10345.927% |
| Huasheng International Holding Limited | 207.84 Million HKD | -218.34% |
| Fourace Industries Group Holdings Limited | 2.39 Million HKD | -27583.891% |
| Evergreen Products Group Limited | 35.17 Million HKD | -1781.17% |
| EC Healthcare | 783.75 Million HKD | 15.58% |
| Ming Fai International Holdings Limited | 2.16 Million HKD | -30475.092% |
| Blue Moon Group Holdings Limited | 101.55 Million HKD | -551.533% |
| SuperRobotics Holdings Limited | 138.44 Million HKD | -377.915% |
| Takbo Group Holdings Limited | 7.72 Million HKD | -8461.659% |
| Hyfusin Group Holdings Limited | 8.66 Million HKD | -7532.311% |